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Abstract: Pertussis is being in-
creasingly found in previously 
immunized subjects. In Nigeria, 
the immunization coverage rates 
are low. This study was therefore 
carried out to highlight the cases 
of pertussis seen in a young Nige-
rian tertiary health facility, with 
emphasis on the clinical features, 
complications and the impact of 
prior immunization in the affected 
children. 
Methods : This was a hospital 
based retrospective study, in 
which data were obtained from 
case notes of children seen in the 
Paediatric department of the Uni-
versity of Uyo Teaching Hospital 
(UUTH) from January 2007 to 
December 2011 with a diagnosis 
of pertussis. Information sought 
included epidemiologic data, du-
ration of illness, signs and symp-
toms, treatment, complications 
and outcome. 
Results: Fifty three patients were 
diagnosed with pertussis during 
the five year period, with majority 
(29; 54.7%) of cases in the year 
2011. Twenty one (39.6%) of the 
subjects were males while 32 
(60.4%) were females. The mean 
age of the subjects was 29.71 + 
27.73 months. The most common 
symptoms were Post-tussive vom-
iting and paroxysmal cough occur-
ring in 48(90%) and 39 (73.6%) of 
the patients respectively. The aver-
age interval between onset of 
symptoms and presentation at the 
health facility was 3.35 + 2.84 
weeks. Majority of the patients 
(25; 47.2%) were adequately im-
munized for their age. Broncho-
pneumonia, either alone or in com-
bination with other complications 
was the commonest complication 
occurring in nine (52.9%) patients. 
There was no mortality. 
Conclusion: Pertussis is still of 
public health significance.  Rou-
tine immunization should be 
strengthened and booster doses of 
vaccines should be considered for 
older children whose immunity 
may begin to wane. 
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Introduction 
 
Pertussis is an acute bacterial infection affecting the 
respiratory tract1. It is caused by Bordetella pertussis 
(B.pertussis) and occasionally Bordetella parapertussis1. 
The illness occurs principally in young unvaccinated 
infants, but school-age children, adolescents and adults 
are affected2. It is usually characterized by progressive, 
repetitive, and paroxysmal coughing1,2,3. Atypical pres-
entations like low grade fever, dyspnoea, apneic epi-
sodes and seizures may occur in children less than two 
years old while, older children and adults have persistent 
cough2,4,5. These unusual forms of presentations often 
lead to misdiagnosis and poor outcome in the affected 
children5. Older siblings are a frequent source of infec-
tion but recent studies are revealing the role of previ-
ously immunized adolescents and adults as reservoir of 
infections2,3,4. 
 
Classic pertussis has an incubation period lasting 7 to 28 
day and the communicability is highest during the first 
two weeks of infection2. After that the disease pro-
gresses through three stages of clinical illness: catarrhal, 
paroxysmal, and convalescent each lasting approxi-
mately two weeks3. Leukocytosis (20,000 to 100,000 
cells/mL) with absolute lymphocytosis is characteristic. 
A chronic cough may persist for several months3. A di-
agnosis of pertussis is usually made clinically, but the 
bordetella DNA maybe detected in polymerase chain 
reaction (PCR) for four weeks after symptom onset, 
except in infants6. The infection can be confirmed by 
culture of the pathogen from nasopharyngeal swabs or 
secretions or by serological test but the latter method is 
not well standardized6,7. 
A number of complications may ensue from the dis-
ease3,8,9.  the most frequent is pneumonia which is seen 
in almost all fatal cases8. Complications like subcon-
junctival haemorrhage, rectal prolapse, otitis media, 
umbilical and inguinal hernias are common in older chil-
dren as against apnea, and encephalopathy in infants3,9.  
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Treatment with antibiotics such as, the macrolides are 
effective in eliminating the bacteria. Even though antibi-
otic therapy does not necessarily alter the clinical course 
of the illness, it has the potential of reducing the period 
of infectivity and modifying the complications of the 
disease10. The recommended treatment is Azithromycin 
for three to five days and Erythromycin and clarithromy-
cin for seven days11,12. 
Primary vaccination with a combination vaccine is the 
proven method of prevention.5 The period of immunity 
induced by the pertussis vaccine tends to wane within 5 
to 10 years and is shorter than that induced by the dis-
ease itself13, hence booster doses are of importance in 
preschool children and adolescents with waning immu-
nity14.  
In spite of the fact that pertussis is a treatable s well as 
a vaccine-preventable childhood illness, the nationl a d 
global incidences of the disease has been on the incr ase 
in recent years1,2,3. This has been attributed to persistent 
low immunization coverage rates, frequent vaccine stock 
outs and erratic power supply leading to breaks in the 
cold chain15,16,17. Currently a waning immunity has  
become a major factor18. 
The aim of this study therefore was, to describe the pat-
tern of clinical presentation and complications of pertus-




Materials and methods 
 
Data were obtained from case notes of children managed 
for pertussis in the paediatric Outpatient clinic and the 
Paediatric ward of the University of Uyo Teaching Hos-
pital (UUTH) from January 2007 to December 2011. 
Information extracted from the case records included th  
patients epidemiologic data, duration of illness, sign  
and symptoms, treatment, complications and outcome. 
The diagnosis of pertussis was based on the Centre for 
Disease Control and Prevention clinical case definitio  
of 199719. A case was defined as coughing illness lasting 
for at least 2 weeks with at least one of the following: 
paroxysms of coughing, inspiratory whoop or post-
tussive vomiting without other apparent cause. A prob-
able case was one that met the clinical case definition 
but was not laboratory confirmed or epidemiologically 
linked to a laboratory-confirmed case.  
 Data was analysed using the SPSS version 17. Descrip-
tive statistics including the measures of central tendency 
(mean) and dispersion (standard deviation) were used. 
Chi-square test was used to test for association between 
categorical variables. A p-value of 0.05 was taken as 
statistically significant. 
Ethical clearance for the conduct of the study was  






Seventy two patients had a diagnosis of pertussis over
the five year period. Their age ranged from one month to 
14 years. Nineteen cases were excluded because they did 
not meet the inclusion criteria.  Therefore fifty three 
cases of pertussis were recorded within the five year 
period (2007-2011). Of this number, 29(54.7%) were 
seen in 2011. (Figure 1.) Twenty one (39.6%) of the 
children were males while 32 (60.4%) were females; 
giving a male to female ratio of 1:1.5. The mean age of 
the children was 29.71 + 27.73 months with a range of 1
-108 months. The proportion of infants (39.6%), were 
similar to those aged 12-59 months (37.7%). 
Of the 53 cases, 16(30.2%) cases had a history of con-
tact with siblings, 25 (47.2%) were adequately immu-
nized for their age, 11 (20.8%) were inadequately immu-
nized for age, while 10 (8.9%) had no immunizations. 
(Table 1). 
The average interval between onset of symptoms and 
presentation at the health facility was 3.35 + 2.84 weeks. 
The mean duration of illness was 6.1±3.66 weeks with a 
range of two to 16 weeks.  
 
Table 1: Socio-demographic characteristics of Paediatric  
Pertussis patients in UUTH from 2007 to 2011   
*Twenty three (43.4%) subjects had been completely immu-
nized with three doses of DPT. 
 
Table 2 shows that all the cases presented with cough, 
which was paroxysmal in 39(73.6%). Post-tussive vom-
iting, occurred in 48(90%), fever in 19(35.8%), while a 
whoop was present in 10(30.2%). The other symptoms 
were catarrh 12(23.6%), difficulty in breathing  
11(20.8%), weight loss in 6(11.3%) and red eye in  
5(9.4%) cases. The signs patients presented with were 
flaring of alae nasi, coarse crepitations and hepa-
tomegaly in 2(3.8%) cases respectively and central cy -
nosis, rhonchi, Subcostal and intercostal recession in  
1(1.9%) case respectively. 
 
There was a statistically significant association between 
age and paroxysmal cough with infants having more 
cases of paroxysmal cough than the older children  
(p =0.044). The association between age and post tus-
sive vomiting or age and occurrence of whoop was not 
statistically significant. 
Of the Seventeen patients that had complications, the 
commonest were bronchopneumonia 6(35.3%) and sub-
conjunctival haemorrhage in 6(35.3%) followed by a  
Socio-demographic 
characteristics 
Frequency (n) Percent (%) 
Age groups 
0 -11months 
12- 59 months 





























    
*Adequate for age 25 54.4 
Not adequate for age 11 23.9 
Nil  10 21.7 
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combination of bronchopneumonia and subconjunctival 
haemorrhage in 2(3.8%) cases.  (Table 2) 
There was no statistical significant association betwe n 
age groups of patients and development of complica-
tions (χ2 = 1.244; p= 0.537) but the association between 
gender and development of complications was statisti-
cally significant with more males having complications 
than females (χ2 = 6.582;  p=0.010). 
Twenty five (47.2%) of the subjects were treated with 
Erythromycin, 18 (34.6%) received Azithromycin, while 
two (3.8%) received a combination of Erythromycin and 
Azithromycin. Other antibiotics received included  
Cefuroxime and Cefpodoxime. 
There were no deaths recorded among the subjects as all 
recovered.  
 
Table 2: Symptoms and signs of pertussis in patients seen in 
UUTH  
*other symptoms include impaired feeding, fast breathing, epistaxis, 
chest pain and haemoptysis 
 
Table 3: Pattern of complications seen in pertussis patients in 
UUTH 
 



















Post-tussive vomitting 48(90.6) Coarse crepitation 2(3.8) 
Fever 19(35.8) Hepatomegaly 2(3.8) 
Whoop 16(30.2) Central cyanosis 1(1.9) 
Catarrh 12(23.6)     
Difficulty in breathing 11(20.8)     
Weight loss 6(11.3)     
Red eye 5 (9.4)     
*Others 8 (15.1)     
Complications Number (%) 
Bronchopneumonia 6(35.3) 
Subconjunctival haemorrhage 6(35.3) 
Bronchopneumonia with sub-conjunctival  
haemorrhage 
2(11.7) 








The importance of pertussis as a vaccine preventable 
disease cannot be overemphasised.  Most of the patints 
with pertussis were seen in 2011. A probable explana-
tion for this local surge of pertussis, may be due to  
increased awareness and an increased index of suspicion 
among doctors. It may also be as a result of poor vaccine 
quality due to poor storage or as a result of the immunity 
gaps being observed across the globe17,18. Another rea-
son may be that the ongoing preparation for the replac -
ment of DPT with pentavalent vaccine in the National 
Programme for Immunization may have led to a disrup-
tion in the supply of DPT vaccines in some states of the 
country, thereby resulting in low DPT coverage. This 
was noted in local records that from 2010 to Novembr 
2011, there were no DPT vaccines in the state. This was 
also corroborated by World Health Organisation (WHO)
when it noted that in the year 2011 an estimated 22 mil-
lion infants worldwide were not reached with routine 
immunization services, with about half of them living in 
three countries which included Nigeria20. The prepon-
derance of infants with pertussis seen in this study has 
also been noted in earlier reports4,21,22.  This is probably 
because mothers provide little if any passive protection 
to young infants3 Majority of the patients were females 
as was also noted in an earlier study23. The reason is 
unknown. In approximately 30% of the patients, a his-
tory of contact with a coughing older sibling was given. 
This is in keeping with earlier reports that show that 
older siblings are a frequent source of infection even if 
they have been vaccinated, although in infants the 
source of infection cannot be detected in 30-69% of cas-
es2,5 This is attributed to waning immunity in the  
absence of booster vaccine17 and the fact that the symp-
tomatology in vaccinated individuals are atypical1,2,5. 
Majority of cases were also seen in adequately immu-
nized patients with 43.7% of them having received  
three doses of DPT vaccine. The explanation for this
may be due to frequent vaccine stock outs and erratic 
power supply leading to breaks in the cold chain and
immunization with suboptimal vaccines17,20.  The aver-
age interval between the onset of symptoms and presen-
tation at the health facility of >21 days in this review 
was longer than the median of 14 days in the study by 
Yaari et al1 in Isreal. This may be due to differences in 
the treatment seeking behaviour of their caregivers24. 
Late presentation in health facilities is a common obser-
vation in the Nigeria especially among those of low 
socio-economic status. It is well known that this interval 
has an implication on the infectivity and spread of the 
causative agent10,11. This is because though early treat-
ment with effective antibiotics does not alter the clinical 
course of the disease, it reduces the period of infectivity 
of the case3,12. 
 
The common symptoms noted were cough (100%), of 
which 73.6% were paroxysmal in nature, post-tussive 
vomiting in 90% and a whoop in only 30% of cases. 
This symptoms are in keeping with the those of earli r 
studies.2,3,18 These symptoms are of great importance as 
they have been shown to be highly sensitive and  
moderately specific for culture confirmation of the diag-
nosis of pertussis3.  It is of note that there was a signifi-
cant association between paroxysmal cough and infancy 
as other studies have reported this finding2,3,18. There 
was a paucity of chest signs among patients in this 
study, which was expected as chest examination find-
ings are usually normal between paroxysms except in 
infants with secondary pneumonia3. 
Bronchopneumonia and Subconjunctival haemorrhage, 
either alone or in combination were the commonest 
complications noted. The only case of apnoea recordd 
was in an infant less than three months of age. These 
findings are in keeping with earlier studies2,3,9. 
The use of the macrolides in the treatment of pertussis in 
majority of the patients showed that the clinicians were 
aware of the recommended antibiotics for the treatmn  
of pertussis10,11. However the total duration of the illness 
in the patients was similar to those obtained in earlier 
literature, an era wherein antibiotics were not insituted 
for patients with the disease. This goes to buttress the 
fact that antibiotic therapy does not alter the clini al 
course of the disease2,3. 
 
No mortality was recorded among patients in this study. 
This could be attributed to the small sample size and to 
the fact that majority of the patients were immunized 
and so did not present with severe and life threatening 
complications. 
The major limitation of this study was absence of labo-
ratory confirmation of the cases. The additional limita-
tion is potential information bias which is common to 
retrospective studies. Other factors that may account for 
the presumed low incidence maybe underreporting due 
to misdiagnosis especially in atypical cases in infants 
(no whoop), poor reporting of diseases generally, possi-
ble lack of awareness and lack of active surveillance25. 
 Also as a hospital based study, this may not give a true 
burden of the disease as the burden in the community 
may be much higher considering the poor health seeking 
behaviour of our local populace and the presence of  






In conclusion, our study documents the clinical andepi-
demiologic pattern of pertussis in the Paediatric Depart-
ment of University of Uyo. We have documented the 
high morbidity in infants, and our study suggests that he 
source of infection may be older siblings and this may 
be a consequence of the delivery of suboptimal vaccines 
and waning vaccine immunity in the context of preva-
lent pertussis disease in the community. More detailed 
studies in the community are needed on laboratory cn-
firmed pertussis cases before evidence-based strategies 
to control the disease in Nigeria can be made.   
We therefore recommend the strengthening of our diag-
nostic capacity as well as our routine immunization ser-
vices. Additional research on laboratory confirmed cases 
as well as on the current immunity of children, adoles-
cents and adults is also required in order to determine 
the need for booster doses of vaccine and at which age 
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